| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 8e-05 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |